✦ LIBER ✦

Liver transplantation for liver cancer

✍ Scribed by R. Y. Calne

Publisher: Springer
Year: 1982
Tongue: English
Weight: 409 KB
Volume: 6
Category: Article
ISSN: 0364-2313
DOI: 10.1007/bf01656376

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transplantation for liver and biliary ca

Transplantation for liver and biliary cancer

✍ Russell W. Strong 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

The early survival of patients transplanted for liver and biliary cancer is excellent, but the overall mid-to long-term survival is poor. In an era of severe donor organ shortage, it is not justified to allocate donor liver to patients with a suboptimal outcome. Patients with nonresectable hepatocel

Primary liver cancer and survival in pat

Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis

✍ Kowdley, Kris V. ;Hassanein, Tarek ;Kaur, Sumanjit ;Farrell, Frank J. ;van Thiel 📂 Article 📅 1995 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 395 KB

Cirrhotic patients with hereditary hemochromatosis (HHC) have an increased risk of primary liver cancer (PLC). The purpose of this study was to determine the prevalence of primary liver cancer in patients with HHC undergoing orthotopic liver transplantation (OLT). Five liver transplant centers were

Is hepatic transplantation justified for

Is hepatic transplantation justified for primary liver cancer?

✍ Robert A. Fisher; Daniel G. Maluf; Luke Wolfe; Bridgette Williams; Adrian Cotter 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

## Abstract A concise, yet objective overview of Hepatocellular Carcinoma (HCC) treatment in 2006 with an intent to transplant is presented. The most significant variables impacting on the use of hepatic transplantation as therapy for primary liver cancer are developed under the headings of: Stagin

Liver transplantation for gastroenteropa

Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival

✍ Frederike G.I. van Vilsteren; Edwina S. Baskin-Bey; David M. Nagorney; Schuyler 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

Liver transplantation for gastroenteropancreatic neuroendocrine cancer (GEP) is controversial. The aim of this study was to assess patient outcomes after liver transplantation for hepatic metastases from GEP. Medical records of patients who underwent liver transplantation for GEP were reviewed. Immu

Development of colon cancer after liver

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis

✍ Hidefumi Higashi; Katsuhiko Yanaga; J. Wallis Marsh; Andreas Tzakis; Saduro Kaki 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

Between February 26, 1981, and July 30, 1987, 36 patients underwent orthotopic liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Three of the 36 recipients died within 3 mo because of graft nonfunction or surgical complications. The other 33 (92%) lived for

Drop-out rates of patients with hepatoce

Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization

✍ Yamini K. Maddala; Linda Stadheim; James C. Andrews; Lawrence J. Burgart; Charle 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Patients with hepatocellular carcinoma (HCC) are assigned model for end stage liver disease (MELD) scores to provide access to liver transplantation (LT). An equitable policy would equate HCC progression beyond acceptable transplantation criteria with death on the waiting list. However, limited info